GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Sensus Healthcare Inc.
Sensus Healthcare produces systems for non-invasive radiation therapy for skin cancer and keloids. Its stock price reflects the adoption of this technology by dermatologists as an alternative to surgery.
Share prices of companies in the market segment - Therapeutic medical equipment
Sensus Healthcare manufactures and markets superficial radiation therapy (SRT) systems used to treat non-melanoma skin cancer and keloids. We've categorized it as "Therapeutic Medical Equipment." The chart below shows how the market values niche solutions in dermatology and oncology.
Broad Market Index - GURU.Markets
Sensus Healthcare manufactures and markets superficial radiation therapy (SRT) systems used to treat non-melanoma skin cancer and keloids. It is a component of the GURU.Markets index. The chart below represents the market. See how this stock compares to the medical device sector.
Change in the price of a company, segment, and market as a whole per day
SRTS - Daily change in the company's share price Sensus Healthcare Inc.
Sensus Healthcare, Inc.'s daily price change reflects volatility in the medical equipment sector. The metric is sensitive to sales of its non-melanoma skin cancer radiation therapy systems.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Sensus Healthcare, Inc. is a medical device company. This chart shows high volatility. Comparing it to SRTS, which focuses on skin cancer treatments, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Sensus Healthcare produces superficial radiation therapy systems for the treatment of skin cancer. The medtech company's stock performance depends on the adoption of its technology in dermatology clinics. Its history reflects the innovative healthcare sector's contribution to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Sensus Healthcare Inc.
Sensus Healthcare, Inc.'s year-over-year performance tells the story of its niche in the radiation therapy market. Its 12-month market cap growth reflects demand from dermatologists for its systems for treating non-melanoma skin cancer and keloid scars, offering patients a non-surgical alternative.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Sensus Healthcare, Inc. is a manufacturer of medical devices for non-invasive skin cancer treatment. This chart illustrates how its niche technology, market expansion efforts, and reliance on physician acceptance of its method impact its performance in the medical device sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sensus, with its skin cancer radiation therapy systems, operates in the protective sector. Demand for its medical equipment is driven not by economics, but by patient needs. The company's stock price reflects stable, non-cyclical growth driven by ongoing demand for its unique technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Sensus Healthcare Inc.
Sensus Healthcare produces radiation therapy systems for non-melanoma skin cancer. Its monthly growth reflects the pace of sales of its SRT-100 systems to dermatologists and oncologists. Quarterly reports on installation growth and revenue are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Sensus Healthcare produces systems for the non-invasive treatment of non-melanoma skin cancer and keloids using superficial radiation therapy. The graph below shows the overall dynamics in the therapeutic medical device sector, where Sensus offers an alternative to surgery.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sensus Healthcare, Inc. produces radiation therapy systems for the treatment of non-melanoma skin cancer. Demand for its equipment depends on clinic budgets and demographic trends. Share price performance is driven by medical equipment sales cycles, which may not align with overall market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Sensus Healthcare Inc.
The weekly performance of Sensus Healthcare, a manufacturer of skin cancer radiation therapy systems, depends on news from the dermatology field. Changes in treatment guidelines, as well as data on equipment purchases by clinics, drive short-term fluctuations.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Sensus Healthcare and the entire medical device industry are responding to general hospital purchasing cycles. Hospital budgets and insurance policies are drivers for everyone. This chart shows how a niche player focused on dermatology compares to industry giants.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Sensus Healthcare and the entire medical device industry are responding to general hospital purchasing cycles. Hospital budgets and insurance policies are drivers for everyone. This chart shows how a niche player focused on dermatology compares to industry giants.
Market capitalization of the company, segment and market as a whole
SRTS - Market capitalization of the company Sensus Healthcare Inc.
Sensus Healthcare's market cap is the financial valuation of a company that produces superficial radiation therapy devices for the treatment of non-melanoma skin cancer. The chart reflects its niche as an alternative to surgery. Its dynamics tell a story about how investors assess its ability to expand the use of this technology among dermatologists.
SRTS - Share of the company's market capitalization Sensus Healthcare Inc. within the market segment - Therapeutic medical equipment
Sensus Healthcare produces superficial radiation therapy (SRT) devices for the treatment of non-melanoma skin cancer and keloids as an alternative to surgery. Its market share reflects its leadership in this niche. The chart below shows the market share of this equipment provider for dermatologists and oncologists.
Market capitalization of the market segment - Therapeutic medical equipment
Sensus Healthcare produces systems for the non-invasive treatment of non-melanoma skin cancer. The graph below shows the overall market capitalization of the therapeutic equipment sector. Its growth reflects the search for more gentle treatment methods. Sensus offers an alternative to traditional surgery for a specific group of patients.
Market capitalization of all companies included in a broad market index - GURU.Markets
The medical equipment seen in the graph can be highly specialized. Sensus Healthcare produces radiation therapy systems for non-melanoma skin cancer and keloid scars. Its market capitalization is based on its niche technology, which offers a non-surgical alternative for treating these conditions.
Book value capitalization of the company, segment and market as a whole
SRTS - Book value capitalization of the company Sensus Healthcare Inc.
Sensus Healthcare is a provider of non-invasive skin cancer treatments. Its book value reflects the expansion of its superficial radiation therapy (SRT) systems, which are an alternative to surgery.
SRTS - Share of the company's book capitalization Sensus Healthcare Inc. within the market segment - Therapeutic medical equipment
Sensus Healthcare produces radiation therapy systems for non-melanoma skin cancer. Its stake in the sector's assets includes the manufacturing facilities for these devices. This physical base allows it to offer a non-invasive alternative to surgery.
Market segment balance sheet capitalization - Therapeutic medical equipment
Sensus Healthcare, Inc. manufactures radiation therapy systems. This is a capital-intensive business, requiring R&D centers and manufacturing facilities to assemble these complex medical devices. Compared to the medical device industry, its model exemplifies a "heavy-duty" manufacturer of specialized equipment.
Book value of all companies included in the broad market index - GURU.Markets
Sensus Healthcare's assets aren't massive accelerators, but rather the production of compact systems for radiation therapy of skin cancer and keloid scars right in dermatologists' offices. The company's balance sheet reflects the value of this niche equipment. The chart shows how much capital has been invested in making oncology more accessible and gentle.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Sensus Healthcare Inc.
Sensus Healthcare produces systems for non-surgical skin cancer treatment. Its market capitalization is based on its proprietary technology and the growing demand for non-invasive treatments. Investors are evaluating its share of this niche medical market.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Sensus Healthcare produces devices for radiation therapy of non-melanoma skin cancer. Its value lies in its patented technology. This chart shows the premium the market pays for its less invasive treatment approach and its position in this specialized medical market.
Market to book capitalization ratio for the market as a whole
Sensus Healthcare produces radiation therapy devices for non-melanoma skin cancer. As a medtech company, its valuation is based on its unique technology and patents. This chart demonstrates the premium investors pay for innovative medical equipment offering an alternative to surgery.
Debts of the company, segment and market as a whole
SRTS - Company debts Sensus Healthcare Inc.
Sensus Healthcare produces radiation therapy systems for skin cancer and keloids. The company's growth depends on sales of its expensive equipment to clinics. Debt financing can be used to expand the sales and marketing team and offer financing options to customers.
Market segment debts - Therapeutic medical equipment
Sensus Healthcare produces radiation therapy systems for skin cancer and keloids. Following the commercialization of its devices, the company invests in sales and marketing. This chart shows how Sensus finances its commercial activities and how its debt policy supports its efforts to expand the use of its technology among dermatologists and oncologists.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Sensus Healthcare Inc.
Sensus Healthcare produces radiation therapy equipment for skin cancer. This chart shows how the company finances the production and sales of its systems. For a medical device manufacturer, debt may be necessary for growth, but it becomes a risk if clinics slow down their purchases due to budget constraints or the emergence of more advanced technologies.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Sensus Healthcare produces superficial radiation therapy devices, which serve as a non-invasive alternative for treating certain types of skin cancer. This chart compares the company's debt to the overall market capitalization of the entire therapeutic medical device sector. It helps assess how the company finances the advancement of its niche technology.
Debt to book value of all companies in the market
Sensus Healthcare manufactures and markets equipment for the treatment of oncological and dermatological diseases. The company's growth depends on its ability to deploy its systems in clinics. The chart shows how it finances its production and marketing. A comparison with the medical device sector allows us to assess the effectiveness of its commercial strategy.
P/E of the company, segment and market as a whole
P/E - Sensus Healthcare Inc.
This chart for Sensus Healthcare, a manufacturer of skin cancer radiation therapy devices, evaluates its niche medical technology. The price-to-earnings ratio shows whether investors believe their method will become a popular alternative to surgery. The trend reflects the rate of adoption of the devices in dermatology clinics.
P/E of the market segment - Therapeutic medical equipment
This chart shows the average valuation for medical device manufacturers—the benchmark for Sensus Healthcare. Comparing this company's valuation for its niche technology with the industry average clearly demonstrates how skeptical the market may be about its chances of widespread clinical adoption.
P/E of the market as a whole
Sensus Healthcare produces superficial radiation therapy devices for the treatment of non-melanoma skin cancer and keloids, offering a non-invasive alternative to surgery. This chart reflects the state of the medical technology sector. It helps understand how demographic trends (aging populations and rising skin cancer rates) and physician adoption of the technology are impacting Sensus' growth.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Sensus Healthcare Inc.
Sensus Healthcare produces superficial radiation therapy (SRT) devices for the treatment of non-melanoma skin cancer and keloids. The company's future growth depends on the adoption of this non-invasive alternative to surgery by dermatologists. This chart shows analysts' confidence in the growth potential of this market and Sensus' technology.
Future (projected) P/E of the market segment - Therapeutic medical equipment
Sensus Healthcare manufactures and markets superficial radiation therapy (SRT) devices, which offer non-invasive treatment for non-melanoma skin cancer and keloids. The chart shows how the company's revenue forecast compares to the industry average, reflecting how the market views its technology as an alternative to surgery.
Future (projected) P/E of the market as a whole
Sensus Healthcare produces systems for non-surgical skin cancer treatment. This chart reflects the overall sentiment in the healthcare sector. For Sensus, the focus isn't so much on economics as on the adoption of their technology by dermatologists and patients. This is a growth story driven by offering a less invasive treatment option.
Profit of the company, segment and market as a whole
Company profit Sensus Healthcare Inc.
Sensus Healthcare manufactures and markets superficial radiation therapy systems for the treatment of non-melanoma skin cancer and keloids, offering a non-invasive alternative to surgery. This chart shows financial results based on sales of its medical equipment to dermatologists and oncologists.
Profit of companies in the market segment - Therapeutic medical equipment
Sensus Healthcare manufactures and markets superficial radiation therapy (SRT) devices, which are used to treat non-melanoma skin cancer and keloid scars as a non-invasive alternative to surgery. This chart shows the overall profitability of the medical device sector, demonstrating the demand for new technologies that improve patients' quality of life.
Overall market profit
Sensus Healthcare produces systems for the treatment of skin cancer and keloids using superficial radiation therapy. Demand for their equipment depends on the budgets of dermatology clinics and hospitals. The introduction of new, expensive equipment is more rapid during periods of economic stability, when medical institutions have the funds to invest.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Sensus Healthcare Inc.
Sensus Healthcare produces superficial radiation therapy devices, which are a non-invasive alternative for treating certain types of skin cancer. This graph reflects analysts' expectations regarding how widely this technology will be adopted by dermatologists and oncologists as a standard of care.
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Sensus Healthcare produces superficial radiation therapy devices used to treat non-melanoma skin cancer and keloid scars without surgery. This chart shows forecasts for the medical device sector. Sensus's profitability depends on the acceptance of its technology by dermatologists and oncologists as an effective alternative to traditional methods.
Future (predicted) profit of the market as a whole
Sensus Healthcare produces systems for non-surgical skin cancer treatment. Demand for such expensive equipment depends on the budgets of clinics and healthcare systems. This graph, showing profit forecasts, helps assess the overall financial health of the economy, which impacts the ability of healthcare institutions to invest in new technologies.
P/S of the company, segment and market as a whole
P/S - Sensus Healthcare Inc.
Sensus Healthcare produces superficial radiation therapy (SRT) devices for the treatment of non-melanoma skin cancer and keloids. This chart shows how investors estimate the revenue from these systems. It reflects the growing demand for non-invasive treatments and the expanding use of its technology by dermatologists.
P/S market segment - Therapeutic medical equipment
Sensus Healthcare manufactures and markets superficial radiation therapy (SRT) systems for the treatment of non-melanoma skin cancer and keloids, offering a non-invasive alternative to surgery. This chart shows the average rating for medical device manufacturers, helping to understand how the market views Sensus' technology and its share of the dermatologic oncology market.
P/S of the market as a whole
Sensus Healthcare manufactures and markets superficial radiation therapy (SRT) devices for the treatment of non-melanoma skin cancer. It is a non-invasive alternative to surgery. This chart shows the premium investors are willing to pay for the company's revenue, which offers an effective and gentle solution for this very common cancer.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Sensus Healthcare Inc.
Sensus Healthcare manufactures and markets superficial radiation therapy (SRT) systems, which are a non-invasive alternative for treating non-melanoma skin cancer. This chart shows investor estimates for the company's future revenue. It reflects expectations for increased adoption of this technology by dermatologists and oncologists.
Future (projected) P/S of the market segment - Therapeutic medical equipment
Sensus Healthcare produces devices for radiation therapy of non-melanoma skin cancers and keloids. This chart compares the company's estimated future sales with its industry. It reflects the market's perception of its niche technology as an alternative to surgery and its level of acceptance by dermatologists.
Future (projected) P/S of the market as a whole
Sensus Healthcare manufactures and markets superficial radiation therapy devices for the treatment of non-melanoma skin cancer and keloids. The optimism demonstrated by this indicator is often fueled by medical innovation. Sensus's growth reflects the demand for non-invasive and effective treatments in dermatology and oncology.
Sales of the company, segment and market as a whole
Company sales Sensus Healthcare Inc.
Sensus Healthcare manufactures and markets superficial radiation therapy devices used to treat non-melanoma skin cancer and keloids. Revenue, shown in this chart, is generated from sales of these medical devices to dermatologists and oncologists.
Sales of companies in the market segment - Therapeutic medical equipment
Sensus Healthcare produces superficial radiation therapy devices used to treat non-melanoma skin cancer and keloid scars. Their technology offers a non-invasive alternative to surgery. This chart illustrates the growing medical equipment market, where gentle and effective treatment methods are increasingly in demand.
Overall market sales
Sensus Healthcare, Inc. manufactures systems for the treatment of skin cancer and keloids using superficial radiation therapy. The growth in overall economic revenue, reflected in this graph, improves funding for dermatology clinics and hospitals. This allows them to invest in new equipment, offering patients non-invasive and effective treatments.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Sensus Healthcare Inc.
Sensus Healthcare, Inc. manufactures superficial radiation therapy (SRT) devices, which offer a non-invasive alternative to surgery for the treatment of non-melanoma skin cancer. This chart shows analysts' expectations for the adoption of this technology in dermatological practice and patient demand.
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Sensus Healthcare manufactures and markets superficial radiation therapy (SRT) systems used to treat non-melanoma skin cancer and keloids without surgery. This chart shows forecasts for the therapeutic equipment sector, illustrating the demand for non-invasive and effective treatments in dermatology and oncology.
Future (projected) sales of the market as a whole
Sensus Healthcare, a manufacturer of skin cancer treatment systems, sees this chart as an indicator of healthcare costs. The economic growth reflected here means dermatology clinics and hospitals can invest more in new equipment, offering patients modern, non-invasive treatments.
Marginality of the company, segment and market as a whole
Company marginality Sensus Healthcare Inc.
Sensus Healthcare manufactures and markets superficial radiation therapy systems for the treatment of non-melanoma skin cancer. The company's profitability depends on sales of this expensive medical equipment to dermatologists and oncologists. This chart shows how successfully the company commercializes its technology, converting revenue into net profit.
Market segment marginality - Therapeutic medical equipment
Sensus Healthcare manufactures and markets superficial radiation therapy devices for the treatment of non-melanoma skin cancer and keloids. Profitability in the medical equipment sector depends on the uniqueness of its technology and the effectiveness of its sales team. The chart below shows how successfully the company competes in the dermatology equipment market.
Market marginality as a whole
Sensus Healthcare produces superficial radiation therapy devices for the treatment of non-melanoma skin cancer and keloids. Based on overall cost-effectiveness data, Sensus offers a non-invasive alternative to surgery. Their profitability depends on the acceptance of their technology by dermatologists and oncologists, as well as insurance coverage.
Employees in the company, segment and market as a whole
Number of employees in the company Sensus Healthcare Inc.
Sensus Healthcare produces non-invasive systems for the treatment of skin cancer and keloids. This chart shows its team, including engineers and sales specialists. The growth of its sales team is a key indicator of the company's efforts to promote its technology to dermatologists and oncologists.
Share of the company's employees Sensus Healthcare Inc. within the market segment - Therapeutic medical equipment
Sensus Healthcare produces superficial radiation therapy systems for the treatment of non-melanoma skin cancer and keloids. This chart shows the percentage of specialists—from medical engineers to clinicians—who are attracted to Sensus in this niche. It reflects its leadership in offering a non-invasive alternative to surgery.
Number of employees in the market segment - Therapeutic medical equipment
Sensus Healthcare manufactures and sells radiation therapy devices for non-melanoma skin cancer and keloids. Its business requires a team of engineers and sales specialists. This chart shows how the company is commercializing its technology. The growth in staff, particularly in sales, reflects its efforts to install systems in dermatologists' offices.
Number of employees in the market as a whole
Sensus Healthcare produces systems for the treatment of skin cancer and keloids. Demand for medical equipment in dermatology and oncology is stable and driven by demographic factors. This chart shows general trends, but an aging population and the need for gentle treatment methods ensure a stable market for Sensus.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Sensus Healthcare Inc. (SRTS)
Sensus Healthcare produces medical equipment. This metric reflects the balance between the value of its technology patents and the efficiency of production and sales. The graph shows how this balance changes as new products are introduced to the market.
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Sensus Healthcare, Inc. manufactures and sells radiation therapy devices for non-melanoma skin cancer and keloids. In the medical device sector, this metric reflects both the uniqueness of the technology and its sales performance. The graph compares the company's market valuation per employee to that of its competitors.
Market capitalization per employee (in thousands of dollars) for the overall market
Sensus Healthcare produces radiation therapy devices used to treat non-melanoma skin cancer and keloids. It is a niche medical technology company. This chart shows how the market values this specialized equipment manufacturer, which offers a non-invasive alternative to surgery.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Sensus Healthcare Inc. (SRTS)
Sensus Healthcare produces medical devices for the treatment of skin cancer (superficial radiation therapy, SRT) and keloids. It is a niche medical business. This chart shows how successfully the company is commercializing its expensive devices. It reflects how much revenue each employee (salesperson, engineer) generates from the sale and maintenance of these systems.
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Sensus Healthcare (SRTS) manufactures and markets medical devices for the treatment of non-melanoma skin cancer and keloids using superficial radiation therapy (SRT). This represents a niche medical equipment market. This chart shows how efficiently the company sells and services its systems to dermatology clinics, generating revenue per employee.
Profit per employee (in thousands of dollars) for the market as a whole
Sensus Healthcare manufactures and sells radiation therapy (SRT) devices, primarily for skin cancer treatment. This segment is in the medical devices sector. This chart shows how successfully the company sells and services its expensive systems. Revenue per employee depends on the margins of the devices and the sales team's ability to convince dermatologists and oncologists of their effectiveness.
Sales to employees of the company, segment and market as a whole
Sales per company employee Sensus Healthcare Inc. (SRTS)
Sensus Healthcare produces devices for radiation therapy of skin cancer and keloids. This graph shows how successfully their equipment is selling to dermatologists and oncologists. The increase in revenue per employee reflects the expansion of their installed base and the effectiveness of their sales and marketing teams.
Sales per employee in the market segment - Therapeutic medical equipment
Sensus Healthcare produces radiation therapy (SRT) devices used to treat non-melanoma skin cancer and keloids. It is a niche MedTech company. This chart shows the average revenue per employee in the sector. It helps assess how productive Sensus's commercial team is in selling its specialized (and expensive) equipment to dermatologists and oncologists.
Sales per employee for the market as a whole
Sensus Healthcare, Inc. (SRTS) manufactures superficial radiation therapy (SRT) devices—a non-invasive treatment for non-melanoma skin cancer and keloids. This chart shows how successfully their sales team is delivering these expensive devices to dermatologists and oncologists.
Short shares by company, segment and market as a whole
Shares shorted by company Sensus Healthcare Inc. (SRTS)
Sensus Healthcare produces superficial radiation therapy (SRT) devices for the treatment of non-melanoma skin cancer. It's an alternative to surgery. The chart shows the number of "bears" betting that dermatologists won't actively adopt this expensive technology or that insurance companies will be reluctant to cover it, limiting Sensus's market potential.
Shares shorted by market segment - Therapeutic medical equipment
Sensus Healthcare offers non-invasive skin cancer treatment (SRT) as an alternative to surgery. This chart reflects the overall pessimism in the sector. If the price rises, investors doubt the technology can compete with traditional methods or anticipate problems with insurers reimbursing the entire segment.
Shares shorted by the overall market
Sensus Healthcare produces radiation therapy equipment for skin cancer—an alternative to surgery. This chart reflects the overall market pessimism. While cancer treatment isn't something to skimp on, hospitals may be delaying the purchase of expensive equipment. When investors fear a downturn, they expect clinics to freeze capital expenditures, which will hurt SRTS sales.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Sensus Healthcare Inc. (SRTS)
Sensus Healthcare produces medical equipment for the treatment of non-melanoma skin cancer and keloids, offering non-surgical solutions. This indicator helps assess market acceptance of their technology, showing "overheating" (above 70) with increasing clinical adoption or "overselling" (below 30) amid competition.
RSI 14 Market Segment - Therapeutic medical equipment
Sensus (SRTS) is "radiation" for *skin*. They make *unique* devices (SRT) for *non-invasive* (without surgery) *treatment* of *non-melanoma* skin cancer* (NMSC). The "Therapeutic medical equipment" (medtech) sector thrives on R&D. RSI\_14\_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is SRTS's growth a "niche" or a general "overheating"?
RSI 14 for the overall market
Sensus Healthcare (SRTS) produces equipment for skin cancer treatment. This chart is an indicator of elective "cosmetic" procedures. During periods of euphoria and stability, patients confidently undergo expensive elective surgeries. During moments of market panic, these "non-urgent" procedures are postponed.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SRTS (Sensus Healthcare Inc.)
Sensus Healthcare produces systems for the non-invasive treatment of skin cancer (non-melanoma) and keloids using superficial radiation therapy (SRT). This chart shows the analysts' average 12-month forecast, reflecting their view of how actively dermatologists will adopt this alternative to surgery.
The difference between the consensus estimate and the actual stock price SRTS (Sensus Healthcare Inc.)
Sensus Healthcare is a medical technology company specializing in superficial radiation therapy (SRT). Their devices offer a non-invasive alternative to surgery for treating skin cancer. This chart shows the difference between the market valuation and the consensus forecast. It reveals whether experts believe this technology will be adopted by dermatologists.
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Sensus Healthcare offers a non-surgical approach to skin cancer treatment. Their SRT devices utilize superficial radiation therapy. The company's success depends on dermatologists' willingness to invest in new equipment. This chart shows analysts' overall expectations for the entire medical device sector. It reflects whether experts believe clinics will see an increase in spending on equipment.
Analysts' consensus forecast for the overall market share price
Sensus Healthcare produces systems for superficial radiation therapy (SRT)—a non-invasive treatment for non-melanoma skin cancer and keloids. It's an alternative to surgery. This chart shows overall market sentiment. For Sensus, whose business is selling expensive medical equipment to dermatologists, the overall optimism is important because it reflects clinics' willingness to invest in capital expenditures.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Sensus Healthcare Inc.
Sensus Healthcare provides a non-invasive alternative for skin cancer treatment. This chart serves as an integral indicator of their razor and blade model. It reflects their ability to sell new razors (high-end SRT systems) and the subsequent revenue stream from blades (service contracts).
AKIMA Market Segment Index - Therapeutic medical equipment
Sensus Healthcare (SRTS) manufactures and markets medical devices for the non-invasive treatment of non-melanoma skin cancer and keloids using superficial radiation therapy (SRT). The chart shows the segment average index, helping investors assess how well Sensus competes with traditional surgical treatments compared to the sector average.
The AKIM Index for the overall market
Sensus Healthcare is a manufacturer of superficial radiation therapy (SRT) for the non-surgical treatment of skin cancer and keloids. This chart, which reflects the market average, provides context. It helps assess how SRT, which depends on equipment sales to dermatologists, compares to overall macroeconomic trends.